Logo image of ALLIX.PA

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

EPA:ALLIX - FR0010131409 - Common Stock

21.25 EUR
-0.45 (-2.07%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALLIX. ALLIX was compared to 101 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. While showing a medium growth rate, ALLIX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALLIX has reported negative net income.
In the past year ALLIX had a positive cash flow from operations.
In the past 5 years ALLIX always reported negative net income.
In multiple years ALLIX reported negative operating cash flow during the last 5 years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

ALLIX has a worse Return On Assets (-7.92%) than 71.30% of its industry peers.
The Return On Equity of ALLIX (-43.66%) is worse than 77.78% of its industry peers.
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

ALLIX has a Gross Margin of 113.33%. This is amongst the best in the industry. ALLIX outperforms 99.07% of its industry peers.
In the last couple of years the Gross Margin of ALLIX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 113.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

More info and screens

1

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The debt/assets ratio for ALLIX has been reduced compared to a year ago.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.94, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.94, ALLIX is doing worse than 74.07% of the companies in the same industry.
A Debt/Equity ratio of 0.81 indicates that ALLIX is somewhat dependend on debt financing.
The Debt to Equity ratio of ALLIX (0.81) is worse than 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACCN/A
WACC8.15%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.88 indicates that ALLIX may have some problems paying its short term obligations.
ALLIX has a Current ratio of 0.88. This is in the lower half of the industry: ALLIX underperforms 71.30% of its industry peers.
A Quick Ratio of 0.88 indicates that ALLIX may have some problems paying its short term obligations.
ALLIX has a worse Quick ratio (0.88) than 71.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.55%, which is quite impressive.
Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 12.96% in the last year.
Measured over the past years, ALLIX shows a quite strong growth in Revenue. The Revenue has been growing by 15.85% on average per year.
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%

3.2 Future

Based on estimates for the next years, ALLIX will show a very strong growth in Earnings Per Share. The EPS will grow by 62.27% on average per year.
The Revenue is expected to grow by 22.44% on average over the next years. This is a very strong growth
EPS Next Y107.79%
EPS Next 2Y78.01%
EPS Next 3Y62.27%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y22.44%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALLIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALLIX is valuated quite expensively with a Price/Forward Earnings ratio of 343.85.
Based on the Price/Forward Earnings ratio, ALLIX is valued a bit more expensive than 64.81% of the companies in the same industry.
ALLIX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE N/A
Fwd PE 343.85
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALLIX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 62.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.01%
EPS Next 3Y62.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALLIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALLIX GROUP

EPA:ALLIX (9/5/2025, 7:00:00 PM)

21.25

-0.45 (-2.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)10-09 2025-10-09
Inst Owners11.9%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap141.95M
Analysts84
Price Target22.95 (8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.42%
PT rev (3m)28.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 343.85
P/S 4.16
P/FCF N/A
P/OCF 91.58
P/B 14.43
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)0.06
Fwd EY0.29%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.23
OCFY1.09%
SpS5.1
BVpS1.47
TBVpS-1.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 113.33%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 149.87%
Cap/Sales 18.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 0.94
F-Score5
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)134.63%
Cap/Depr(5y)153.59%
Cap/Sales(3y)19.11%
Cap/Sales(5y)22.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
EPS Next Y107.79%
EPS Next 2Y78.01%
EPS Next 3Y62.27%
EPS Next 5YN/A
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y22.44%
Revenue Next 5YN/A
EBIT growth 1Y40.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.43%
EBIT Next 3Y66%
EBIT Next 5YN/A
FCF growth 1Y40.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.57%
OCF growth 3Y-37.14%
OCF growth 5YN/A